How a hospital has made $4bn in profits from a drug-maker’s deal

A hospital in Pennsylvania that has spent years trying to convince the U.S. Food and Drug Administration to approve its experimental drug for treating COVID-19 has made more than $4 billion in profits since it began selling it in 2014, according to regulatory filings.

The hospital’s drugmaker, AstraZeneca, paid about $4.3 billion in cash and stock awards, according a filing in Delaware with the U